Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 847 results for "nexium"

Ranbaxy loses exclusive rights to produce generic Nexium
Money Today

Teva to gain post Ranbaxy's exclusivity loss for Nexium

Ranbaxy has lost out on its last big drug opportunity in the US market. The US drug regulator has denied the company 180-day exclusivity for the generic version of heart burn drug Nexium. However Archana Shukla reports that Ranbaxy's loss means good times for ... Money Control, 3 hours ago
[x]  

11 images for nexium

Financial Express, 6 hours ago
Examiner.com, 5 hours ago
Pharma Letter, 5 hours ago
MedPage Today, 4 hours ago
Business Standard India, 12 hours ago
Philadelphia Business Journal, 23 hours ago
Philadelphia Business Journal, 23 hours ago
Reuters, 23 hours ago
Yahoo! News, 1 day ago
Nasdaq, 2 weeks ago

Cipla to gain from Teva's exclusivity on Nexium

The revenue expected from exclusive sales of the Nexium generic in US is estimated at around $170 million. New Delhi: The US Food and Drug Administration (FDA) has permitted Teva Pharmaceuticals Industries Ltd to sell a generic version of ...
 Livemint.com1 hour ago Ranbaxy loses exclusivity on heartburn drug in US  Business Standard3 hours ago

Generic Form of Nexium Approved

By Scott Roberts, HealthDay Reporter MONDAY, Jan. 26, 2015 (HealthDay News) -- The first generic version of the heartburn drug Nexium (esomeprazole) has been approved by the U.S. Food and Drug Administration. The drug helps treat GERD, which ...
 US News & World Report22 hours ago FDA OKs First Generic Version of Heartburn Drug Nexium  US News & World Report22 hours ago Generic Form of Nexium Approved-January 26, 2015  InteliHealth20 hours ago
[x]  

Deutsche Bank Offers Quick Thoughts On Teva Pharmaceutical's Generic Nexium

In a report published Tuesday, Deutsche Bank analyst Gregg Gilbert reiterated a Buy rating and $65.00 price target on Teva Pharmaceutical Industries Ltd. (NYSE: TEVA). In the report, Deutsche Bank noted, TEVA announced a final approval for its ...
 Benzinga.com6 hours ago
[x]  

BUZZ-India's Cipla surges to record high on generic Nexium supply hopes

** India's Cipla rises as much as 4.8 pct to record high of 710 rupees ** U.S. Food and Drug Administration approves Teva's generic version of AstraZeneca's blockbuster heartburn drug Nexium** Cipla is expected to supply the drug to Teva, which ...
 London South East11 hours ago Cipla surges to record high on generic Nexium supply hopes  Economic Times10 hours ago
[x]  

BUZZ-AstraZeneca: generic Nexium arrives in US, 8 mths late

** Generic version of AstraZeneca's blockbuster heartburn & ulcer pill Nexium finally set to reach US mkt, 8 mths after medicine lost US exclusivity at end-May 2014** Green light for Teva's generic follows manufacturing problems at India's Ranbaxy, ...
 London South East11 hours ago Is A Generic Nexium Purple Pill For You?  24/7 Wall St23 hours ago

Nexium-Mups-Drug Insights,2014

Summary 'Nexium-Mups - Drug Insights, 2014' provides Nexium-Mups marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, ...
 Individual.com1 week ago Nexium-Mups-API Insights, 2014  MarketResearch.com1 month ago
Livemint.com

AstraZeneca could face hefty damages in Nexium case

News Editor AstraZeneca (NYSE:AZN) could be on the hook for substantial damages if it loses a trial in Boston involving Ranbaxy Laboratories Ltd. (OTC:RBXLY) (OTC:RBXZF) and their pay-to-delay agreement that blocked generic competition to Nexium.
 Seeking Alpha1 month ago AstraZeneca Fights Billions in Possible Damages in Nexium Trial  Bloomberg1 month ago
Financial Express

AstraZeneca, Ranbaxy Laboratories prevail, Nexium drug deal not anti-competitive

Summary In a landmark judgement for pharma sector, a US jury has ruled that AstraZeneca's patent litigation settlement for blockbuster drug Nexium… The lawsuit challenged a settlement between AstraZeneca and Ranbaxy Laboratories that allowed ...
 Financial Express1 month ago AstraZeneca sues Aurobindo over blood sugar drug patent  Financial Chronicle1 month ago AstraZeneca-Ranbaxy drug settlement not anti-competitive  Business Standard1 month ago
Reuters

Class Status Upheld for Nexium Antitrust Suit

By JACK BOUBOUSHIAN (CN) - Union health funds alleging that AstraZeneca paid generic drugmakers not to challenge its Nexium patents were properly certified as a class, the 1st Circuit ruled. AstraZeneca owns several patents related to its ...
 Courthouse News Service1 day ago Astra says U.S. Nexium antitrust case returns favourable ruling  CNBC1 month ago Massachusetts Court Rules In AstraZeneca's Favour In Nexium Case  London South East1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less